S8 Ep19: FDA Approval Insights: Tucatinib and Trastuzumab in HER2+ mCRC
Feb 6, 2023
09:36
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Strickler discusses the FDA approval of tucatinib plus trastuzumab in metastatic colorectal cancer, key efficacy and safety findings from the MOUNTAINEER trial, and ongoing research seeking to address remaining unmet needs in this population.
